1-8 of 8
C F Stewart
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase.

Available to Purchase
S M Guichard, C L Morton, E J Krull, C F Stewart, M K Danks, P M Potter
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (12): 3089–3094.
Published: 01 December 1998
View articletitled, Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase.
Open the PDF for Conversion of the CPT-11 metabolite APC to SN-38 by rabbit liver carboxylesterase. in another window
Journal Articles

A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma.

Available to Purchase
W C Zamboni, A J Gajjar, T D Mandrell, S L Einhaus, M K Danks, W P Rogers, R L Heideman, P J Houghton, C F Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (10): 2537–2544.
Published: 01 October 1998
View articletitled, A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma.
Open the PDF for A four-hour topotecan infusion achieves cytotoxic exposure throughout the neuraxis in the nonhuman primate model: implications for treatment of children with metastatic medulloblastoma. in another window
Journal Articles

Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays.

Available to Purchase
C A Pawlik, P J Houghton, C F Stewart, P J Cheshire, L B Richmond, M K Danks
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (8): 1995–2002.
Published: 01 August 1998
View articletitled, Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays.
Open the PDF for Effective schedules of exposure of medulloblastoma and rhabdomyosarcoma xenografts to topotecan correlate with in vitro assays. in another window
Journal Articles

Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.

Available to Purchase
W C Zamboni, C F Stewart, P J Cheshire, L B Richmond, S K Hanna, X Luo, C Poquette, J P McGovren, J A Houghton, P J Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (3): 743–753.
Published: 01 March 1998
View articletitled, Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models.
Open the PDF for Studies of the efficacy and pharmacology of irinotecan against human colon tumor xenograft models. in another window
Journal Articles

Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.

Available to Purchase
W C Zamboni, A J Gajjar, R L Heideman, J H Beijnen, H Rosing, P J Houghton, C F Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (3): 783–789.
Published: 01 March 1998
View articletitled, Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma.
Open the PDF for Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma. in another window
Journal Articles

Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts.

Available to Purchase
W C Zamboni, P J Houghton, J Thompson, P J Cheshire, S K Hanna, L B Richmond, X Lou, C F Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (1998) 4 (2): 455–462.
Published: 01 February 1998
View articletitled, Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts.
Open the PDF for Altered irinotecan and SN-38 disposition after intravenous and oral administration of irinotecan in mice bearing human neuroblastoma xenografts. in another window
Journal Articles

Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.

Available to Purchase
J Thompson, W C Zamboni, P J Cheshire, L Lutz, X Luo, Y Li, J A Houghton, C F Stewart, P J Houghton
Journal: Clinical Cancer Research
Clin Cancer Res (1997) 3 (3): 423–431.
Published: 01 March 1997
View articletitled, Efficacy of systemic administration of irinotecan against neuroblastoma xenografts.
Open the PDF for Efficacy of systemic administration of irinotecan against neuroblastoma xenografts. in another window
Journal Articles

Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts.

Available to Purchase
J A Houghton, P J Cheshire, C L Morton, C F Stewart
Journal: Clinical Cancer Research
Clin Cancer Res (1995) 1 (1): 33–40.
Published: 01 January 1995
View articletitled, Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts.
Open the PDF for Potentiation of 5-fluorouracil-leucovorin activity by alpha2a-interferon in colon adenocarcinoma xenografts. in another window